Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
NANOBIOTIX Announces Curadigm Nanoprimer Platform Advancements With Updated Plans for Internal Pipeline Development and External Collaborations
-
SAIC Announces Organizational Changes Intended to Simplify Structure, Sharpen Focus and Deliver Sustainable Long-Term Growth and Shareholder Value Creation
-
Inno Holdings Inc. Announces $50 Million “At-the-Market” Equity Offering Program
-
EZCORP Reports Fourth Quarter and Full Year Fiscal 2025 Results
-
Nyxoah Reports Third Quarter 2025 Financial and Operating Results
-
Figure Technology Solutions Reports Third Quarter 2025 Results
-
Acrivon Therapeutics Reports Third Quarter 2025 Financial Results and Business Highlights
-
MediaAlpha Appoints Insurance Industry Veteran Ramon Jones to Board of Directors
-
ORIC® Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Clinical and Operational Updates
-
Fennec Pharmaceuticals Announces Proposed Offering of Common Shares
-
BioSyent Schedules Q3 and YTD 2025 Earnings Release for November 20, 2025
-
Urbana Corporation Has Filed 2025 Third Quarter Interim Financial Statements
-
Equillium Reports Third Quarter 2025 Financial Results and Provides Operational Update
-
First Watch Restaurant Group, Inc. to Participate at the Stephens Annual Investment Conference on November 18-19, 2025
-
PacBio to Present at Upcoming Investor Conferences
-
Cartesian Therapeutics Announces Strong Efficacy Signal in Phase 2 Trial of Descartes-08 in Patients with SLE and Expansion of Clinical Development into Myositis
-
Jade Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update
-
Vaxart Provides Business Update and Reports Third Quarter 2025 Financial Results
-
BioAtla Reports Third Quarter 2025 Financial Results and Highlights Recent Progress
-
Birchtech Reports Third Quarter 2025 Financial Results
-
Reviva Reports Third Quarter 2025 Financial Results and Recent Business Highlights
-
Merit Medical Provides Update on U.S. Reimbursement and Commercial Strategies for WRAPSODY® Cell-Impermeable Endoprosthesis
-
Hudson Technologies Appoints Kenneth Gaglione as Chairman of the Board, President and Chief Executive Officer
-
STRATA Skin Sciences Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
-
Spero Therapeutics Announces Third Quarter 2025 Operating Results and Provides a Business Update
-
SeaStar Medical Reports Third Quarter 2025 Financial Results and Provides Business Updates
-
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2025
-
eGain to Participate in the Roth Technology Conference on November 19, 2025
-
Fluent Announces Third Quarter 2025 Financial Results; Commerce Media Solutions Annual Revenue Run Rate Exceeds $85 Million and Represents 40% of Consolidated Revenue
-
CapsoVision Reports Third Quarter 2025 Financial Results
-
Nasdaq Executives to Present at Upcoming Investor Conferences
-
Hyperion DeFi Reports Third Quarter 2025 Financial Results with Record Net Income of $6.6 Million
-
Profound Medical Reports Strong Third Quarter 2025 Financial Results
-
Shimmick Corporation Announces Third Quarter 2025 Results
-
RenovoRx Reports Third Quarter 2025 Financial Results, Including Approximately $900,000 in Year-to-Date Revenue, and Provides Business Update
-
Aardvark Therapeutics Reports Third Quarter 2025 Financial Results and Provides Pipeline and Business Updates
-
Xos Extends Profitability Streak with Strong Q3 2025 Performance and Positive Operating Cash Flow
-
Jefferson Capital Reports Third Quarter 2025 Results
-
Glucotrack Reports Third Quarter 2025 Financial Results and Provides Update on Recent Corporate Highlights
-
Red Cat Holdings Reports Q3 2025 Revenue Growth of 646% Y/Y Sequential Quarterly Revenue Growth of 200%; Guides Q4 Revenue to 1455% Y/Y; FY 2025 Revenue Guidance to 124% Y/Y, Beating Q3 Revenue Consen
-
AirJoule Technologies (NASDAQ: AIRJ) Announces Third Quarter 2025 Results and Provides Business Update
-
Aterian Reports 2025 Third Quarter Financial Results and Reiterates Guidance
-
zSpace Reports Third Quarter 2025 Financial Results
-
The Oncology Institute Reports Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance
-
Cibus Reports Third Quarter Financial Results and Provides Year-to-Date Business Update for 2025
-
Flux Power Reports Fiscal Year 2026 First Quarter Financial Results
-
Expion360 Reports Third Quarter 2025 Financial and Operational Results
-
Intchains Group Limited Reports Third Quarter and Nine Months 2025 Financial Results
-
Autolus Therapeutics to Participate in the Jefferies Global Healthcare Conference in London
-
Astera Labs Announces Fourth Quarter 2025 Financial Conference Participation

